Edaravone for the treatment of acute cerebral infarction: role of endothelium-derived nitric oxide and oxidative stress
- 20 January 2009
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 10 (2) , 323-331
Abstract
(2009). Edaravone for the treatment of acute cerebral infarction: role of endothelium-derived nitric oxide and oxidative stress. Expert Opinion on Pharmacotherapy: Vol. 10, No. 2, pp. 323-331. doi: 10.1517/14656560802636888Keywords
This publication has 73 references indexed in Scilit:
- Induced hypothermia and fever control for prevention and treatment of neurological injuriesThe Lancet, 2008
- Roles of Rho-Associated Kinase and Oxidative Stress in the Pathogenesis of Aortic StiffnessJACC, 2007
- The Antioxidant Edaravone Attenuates Pressure Overload–Induced Left Ventricular HypertrophyHypertension, 2005
- Edaravone, a novel radical scavenger, inhibits oxidative modification of low-density lipoprotein (LDL) and reverses oxidized LDL-mediated reduction in the expression of endothelial nitric oxide synthaseAtherosclerosis, 2005
- Effect of edaravone, a novel free radical scavenger, on endothelium-dependent vasodilation in smokersThe American Journal of Cardiology, 2004
- Myocardial protection of MCI-186 in rabbit ischemia–reperfusionLife Sciences, 2002
- Free radicals in central nervous system ischemia.Stroke, 1990
- Effect of MCI-186 on ischemia-induced changes in monoamine metabolism in rat brain.Stroke, 1989
- Effect of MCI-186 on brain edema in rats.Stroke, 1989
- Endothelium and control of vascular function. State of the Art lecture.Hypertension, 1989